In Depth

Featured article

Inside the world of priority review vouchers where time is money

Also in this section

Quality and sustainability: The balancing act for pharma manufacturing

2023 in review: Cancer vaccines dose up on advances with tailored approaches

Diversity and ePROs: Still siloed concepts in the era of DCTs?

Q&A: Tackling the rise of fake anti-obesity drugs on the market

Patching the problem of EU drug shortages

Out-of-spec cell therapy manufacturing: an ethical dilemma for CDMOs